AbbVie puckers up for Botox-maker

Forex 3 minutes to read

Michael O’Neill

FX Trader, Loonieviews.net

Summary:  Big pharma is hitting the headlines today after AbbVie Inc (ABBV: NYSE) puckered up, then ponied up $63.0 billion in cash and stock to acquire Botox-maker Allergan (AGN: NYSE).


Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each AGN share, making the deal worth $188.24/per AGN share. The combined companies are projected to generate $19.0 billion in operating cash flow with expected annual synergies and cost savings of $2.0 billion in year three. Closing is planned for early 2020, subject to regulatory and AGN shareholder approvals. AGN jumped 30%, and ABBV lost 10.17% at the New York open.

The news wasn’t enough for Wall Street to extend the June rally. The three major indices were modestly lower as of 14:00 GMT but are still up over 4.0% for the month. Mixed US data, which included a slightly softer Case-Shiller Home Price Index. (Actual 2.5% vs forecast 2.6%) was ignored.

Traders that believe the stock market rally was because of the Fed’s dovish shift and the prospect of two rate cuts before the end of the year, would be wrong. President Trump tweeted the real reason for the gains: “Stock Market is heading for one of the best months (June) in the history of our Country. Thank you Mr. President!”

USDCAD drifted lower, probing support in the 1.3130-50 zone. Prices are under pressure due to the surge in crude oil prices and from broad US dollar weakness. A surprising jump in Canadian Wholesale Sales in April (actual 1.7% m/m vs forecast 0.2%) added to the negative sentiment. 

FX markets remain cautious do the ongoing US/Iran tensions and ahead of news from the next round of China/US trade talks. Fed Chair Powell is speaking at lunchtime in New York but isn’t expected to deviate from his post-FOMC press conference remarks.
Chart:USDCAD 30 minute. Source: Saxo Bank.

Saxo Bank A/S - Representative Office
Boulevard Plaza - Tower 1
30th floor, office 3002
Dubai Downtown, Burj Khalifa area
Dubai
UAE

UAE

Trade responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more

Saxo Bank A/S is licensed by the Danish Financial Supervisory Authority and operates in the UAE under a representative office license issued by the Central bank of the UAE.

The content and material made available on this website and the linked sites are provided by Saxo Bank A/S. It is the sole responsibility of the recipient to ascertain the terms of and comply with any local laws or regulation to which they are subject.

The UAE Representative Office of Saxo Bank A/S markets the Saxo Bank A/S trading platform and the products offered by Saxo Bank A/S.